Web Analytics

3 Latest Announced Rounds

  • $25,000,000
    Series A

    4 Investors

    Software Development
    Nov 13th, 2024
  • $3,506,525
    Unknown
    Advertising Services
    Nov 13th, 2024
  • $5,500,000
    Unknown

    2 Investors

    Mental Health Care
    Nov 13th, 2024
$356.81M Raised in 41 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Generare

start up
France - Paris, Île-de-France
  • 08/10/2024
  • Seed
  • $5,495,250

Natural products have contributed more than 500 molecules to pharmaceuticals.
However, conventional methods for discovering new natural products are increasingly ineffective.

Generare has developed a revolutionary platform that identifies and expresses a wide range of naturally occurring secondary metabolites, selected by millions of years of bacterial evolution.

This platform allows us to reintroduce these lead molecules into clinical pipelines, reopening a validated avenue for therapeutic innovation.


Related People

Guillaume VandeneschFounder

Guillaume Vandenesch France - Paris, Île-de-France

Biotech Engineer with 10+ years exp in innovation & and consulting.
- Successful exit Possible Future 2022 to Capgemini Invent

Launched Generare in March 23' to revolutionize early drug discovery

Generare is a data-driven discovery platform that will revive the field of natural products, bringing this historically successful modality into the clinical pipelines.

Our POC in Nat Coms by Dr. Vincent Libis : http://bit.ly/3RL6JPL

Underlying tech awarded with ERC Starting Grant

More info about Generare available at https://docsend.com/view/dvwzjcj6n4vx36y9